SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193805-03-000696
Filing Date
2003-08-13
Accepted
2003-08-13 15:11:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G e300567_edelman-13g.txt SC 13G 10294
  Complete submission text file 0001193805-03-000696.txt   12236
Mailing Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069
Business Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069 8477932458
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60689 | Film No.: 03840841
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FIRST NEW YORK SECURITIES, LLC 850 THIRD AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Filed by) CIK: 0001164426 (see all company filings)